SHANGHAI, Feb 11 (Reuters) - Eli Lilly has won Chinese regulators' approval for its drug to treat chronic inflammatory bowel ...

By Rishika Sadam and Kashish Tandon HYDERABAD, Feb 17 (Reuters) - Mounjaro-maker Eli Lilly wants to turn India into a hub for its global supply chain, a senior executive at the U.S. drugmaker said, as ...

Eli Lilly isn't a one-trick pony.

Analysis highlights how regulatory divergence in two major pharmaceutical markets could shape future access to emerging ...

American pharmaceutical giant Eli Lily is eyeing to make India a hub of its global supply chain. The commitment is a part of ...

Eli Lilly aims to establish India as a key hub for its global supply chain. The company plans to export drugs manufactured ...

Apple, more than any other company, catalysed the smartphone revolution, inadvertently placing Ireland at the centre of it. The State might be about to ride another technology gear change, this time ...

A new diagnostic test developed by Indianapolis medical giants can help identify or rule out Alzheimer’s in patients with cognitive symptoms.

Eli Lilly aims to transform India into a pivotal hub for its global supply chain through a $1 billion investment, focusing on contract manufacturing. The company's weight-loss drug Mounjaro has surged ...

In one corner: consumers fed up with high drug prices. In the other: pharmaceutical companies arguing that price controls stifle innovation. The still-resonant 2003 documentary 'The Other Drug War' is ...